Highnoon Laboratories Income Statement

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	27,706	24,641	19,766	15,816	13,001
Revenue Growth (YoY)	12.44%	24.66%	24.98%	21.65%	21.53%
Cost of Revenue	12,514	12,236	10,368	7,625	6,475
Gross Profit	15,192	12,405	9,398	8,190	6,526
Selling, General & Admin	8,304	6,865	5,720	4,649	3,985
Research & Development	10.79	9.47	15.02	10.63	8.67
Other Operating Expenses	560.18	533.91	-46.41	321.04	219.11
Operating Expenses	8,875	7,408	5,688	4,981	4,213
Operating Income	6,317	4,997	3,710	3,209	2,313
Interest Expense	-114.01	-395.03	-149.21	-57.07	-27.44
Interest & Investment Income	58.97	151.36	99.43	233.75	132.59
Currency Exchange Gain (Loss)	-23.31	1.37	-335.58	-7.15	2.52
Other Non Operating Income (Expenses)	4.82	12.94	45.33	38.79	-2.42
EBT Excluding Unusual Items	6,244	4,768	3,370	3,418	2,418
Gain (Loss) on Sale of Investments	344.77	236.95	-24.44	9.25	10.59
Gain (Loss) on Sale of Assets	15.53	27.9	13.82	18.17	6.75
Pretax Income	6,604	5,032	3,359	3,445	2,436
Income Tax Expense	2,476	1,644	911.61	972.46	579.32
Earnings From Continuing Operations	4,128	3,389	2,448	2,473	1,856
Net Income	4,128	3,389	2,448	2,473	1,856
Net Income to Common	4,128	3,389	2,448	2,473	1,856
Net Income Growth	21.83%	38.44%	-1.01%	33.20%	25.96%
Shares Outstanding (Basic)	53	53	53	53	53
Shares Outstanding (Diluted)	53	53	53	53	53
EPS (Basic)	77.92	63.95	46.20	46.67	35.04
EPS (Diluted)	77.92	63.95	46.20	46.67	35.04
EPS Growth	21.83%	38.44%	-1.01%	33.20%	25.96%
Free Cash Flow	1,365	4,143	883.21	-1,237	1,430
Free Cash Flow Per Share	25.76	78.20	16.67	-23.34	26.99
Dividend Per Share	50.000	40.000	30.000	15.810	14.373
Dividend Growth	25.00%	33.33%	89.75%	10.00%	46.67%
Gross Margin	54.83%	50.34%	47.55%	51.79%	50.20%
Operating Margin	22.80%	20.28%	18.77%	20.29%	17.79%
Profit Margin	14.90%	13.75%	12.38%	15.63%	14.28%
Free Cash Flow Margin	4.93%	16.81%	4.47%	-7.82%	11.00%
EBITDA	6,657	5,252	3,908	3,392	2,480
EBITDA Margin	24.03%	21.31%	19.77%	21.45%	19.08%
D&A For EBITDA	339.35	254.82	198.44	182.75	166.87
EBIT	6,317	4,997	3,710	3,209	2,313
EBIT Margin	22.80%	20.28%	18.77%	20.29%	17.79%
Effective Tax Rate	37.49%	32.67%	27.14%	28.23%	23.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.